Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Early Psychosis Intervention - Spreading Evidence-based Treatment [NA]
This completed clinical trial update reports on early psychosis intervention and the spread of evidence-based treatment for first-episode ps…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Supportive Psychotherapy as Adjunct to Risperidone for Cognitive Function and Inflammation in Schizophrenia [Phase 2]
A Phase 2 clinical trial evaluating supportive psychotherapy as an adjunct to risperidone for improving cognitive function and inflammation-…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia [Phase 3]
Phase 3 clinical trial update evaluating KarXT for acutely psychotic schizophrenia in Japanese adults; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Cerebellar Modulation of Cognition in Psychosis [NA]
This clinical trial update shows a study on cerebellar modulation of cognition in psychosis that is currently recruiting. The study covers s…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients [Phase 3]
This Phase 3 clinical trial is recruiting to test whether metformin can alleviate statin-induced abnormal glucose metabolism in patients wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Impact of Cannabis Consumption on Psychotic Symptoms and Reality Monitoring in Patients With Schizophrenia: a Real-life Study [Phase 1, Phase 2]
A real-life Phase 1/2 study investigating how cannabis consumption influences psychotic symptoms and reality monitoring in patients with sch…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways [NA]
This entry reports a clinical trial evaluating non-invasive brain stimulation with transcranial direct current stimulation (tDCS) targeting …
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder [Phase 1]
Phase 1 clinical trial assessing safety, tolerability, and pharmacokinetics of lumateperone long-acting injectable formulations in people wi…
-
CLINICAL_TRIALS withdrawal · 2026-03-12Clinical Trial Update: Lifestyle MIND- Feasibility of Wait-list Control [NA]
A feasibility trial of a Lifestyle MIND intervention for individuals with Type 2 diabetes mellitus and serious mental illness (including sch…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study [NA]
A Rutgers-led clinical trial studying decision-making in schizophrenia using neuroimaging and experience sampling; recruitment is currently …
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia [Phase 3]
This document reports an extension Phase 3 trial to evaluate the long-term safety and tolerability of adjunctive KarXT for schizophrenia; re…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Feasibility, Acceptability, and Preliminary Efficacy of Yoga-based Group Intervention for Outpatients With Schizophrenia Spectrum Disorders [NA]
This clinical trial update assesses the feasibility, acceptability, and preliminary efficacy of a yoga-based group intervention for outpatie…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers
This clinical trial update describes ongoing brain imaging studies in childhood-onset psychiatric and endocrine disorders, along with health…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Time and Virtual Reality in Schizophrenia and Bipolar Disorder [NA]
A clinical trial evaluating time and virtual reality interventions for schizophrenia and bipolar disorder is currently recruiting.
-
EMA other · 2026-03-10EMA Opinion under re-examination: Iloperidone Vanda Pharmaceuticals (iloperidone) — Vanda Pharmaceuticals Netherlands B.V.
EMA has issued an opinion under re-examination for iloperidone by Vanda Pharmaceuticals Netherlands B.V. for schizophrenia and bipolar disor…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Repetitive TMS & Cognitive Training in Adults With Schizophrenia [NA]
The study evaluating repetitive transcranial magnetic stimulation (rTMS) and cognitive training in adults with schizophrenia was terminated …
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
A recruiting clinical trial evaluating biomarkers and biotypes, disease course in early psychosis, and specialty services for schizophrenia-…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: EXPRESSIVE ARTS THERAPY FOR HOPE IN PEOPLE WITH SCHIZOPHRENIA [NA]
This clinical trial update notes the completion of a study on expressive arts therapy for people with schizophrenia.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Vaping and Smoking Project in People With Schizophrenia [NA]
A clinical trial is recruiting to compare acute abstinence from cigarettes versus electronic cigarettes (ENDS) in people with schizophrenia.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Deep Brain Stimulation in Treatment Resistant Schizophrenia [NA]
Johns Hopkins is recruiting participants for a deep brain stimulation trial targeting treatment-resistant schizophrenia.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia [Phase 2]
A Phase 2 clinical trial evaluating ML-007C-MA for schizophrenia in inpatient adults is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Prebiotic Treatment in People With Schizophrenia [NA]
This clinical trial update notes an ongoing study evaluating a prebiotic treatment in individuals with schizophrenia and schizoaffective dis…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory Processing [NA]
A completed clinical trial evaluating whether personalizing cognitive remediation to early auditory processing impairments improves cognitiv…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Transcranial Direct Current Stimulation (tDCS) in Different Psychiatric Disorders [NA]
This update notes the completion of a study evaluating transcranial direct current stimulation (tDCS) across multiple psychiatric disorders.…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia [Phase 3]
Phase 3 trial of NBI-1117568 in inpatient adults with schizophrenia is currently recruiting. The study is sponsored by Neurocrine Bioscience…